Lori Bisson - 11 Aug 2025 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Role
Director
Signature
/s/ Trent Smith, Attorney-in-Fact for Lori Bisson
Issuer symbol
AMIX
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
13 Aug 2025, 21:12:16 UTC
Previous filing
24 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bisson Lori Director 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS /s/ Trent Smith, Attorney-in-Fact for Lori Bisson 13 Aug 2025 0001768578

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMIX Option (Right to buy) Disposed to Issuer -18,862 -28% 47,930 11 Aug 2025 Common Stock 18,862 $26.56 Direct F1
transaction AMIX Option (Right to buy) Disposed to Issuer -46,680 -97% 1,250 11 Aug 2025 Common Stock 46,680 $40.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.
F2 Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25,2024.